Earnings Feed
Start Free
Home/Filings/4/0001193125-25-301017
4//SEC Filing

Rosenberg Ellen 4

Accession 0001193125-25-301017

CIK 0001178879other
View on SEC.govCompany Profile

Filed

Nov 25, 7:00 PM ET

Accepted

Nov 26, 9:16 PM ET

Size

22.3 KB

Accession

0001193125-25-301017

Insider Transaction Report

Form 4
Period: 2025-11-24
AMICUS THERAPEUTICS, INC.FOLD
Rosenberg Ellen
Chief Legal Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2025-11-24$6.10/sh+25,000$152,500→ 532,710 total
  • Exercise/Conversion

    Common Stock

    2025-11-24$5.13/sh+11,000$56,430→ 543,710 total
  • Sale

    Common Stock

    2025-11-24$10.06/sh−36,000$362,268→ 507,710 total
  • Exercise/Conversion

    Common Stock

    2025-11-25$5.13/sh+36,000$184,680→ 543,710 total
  • Sale

    Common Stock

    2025-11-25$10.00/sh−36,000$360,000→ 507,710 total
  • Exercise/Conversion

    Common Stock

    2025-11-26$5.13/sh+23,621$121,176→ 531,331 total
  • Sale

    Common Stock

    2025-11-26$10.00/sh−23,621$236,210→ 507,710 total
  • Exercise/Conversion

    Stock Options (right to buy)

    2025-11-24−25,000→ 0 total
    Exercise: $6.10Exp: 2026-06-15→ Common Stock (25,000 underlying)
  • Exercise/Conversion

    Stock Options (right to buy)

    2025-11-24−11,000→ 59,621 total
    Exercise: $5.13Exp: 2027-01-03→ Common Stock (11,000 underlying)
  • Exercise/Conversion

    Stock Options (right to buy)

    2025-11-25−36,000→ 23,621 total
    Exercise: $5.13Exp: 2027-01-03→ Common Stock (36,000 underlying)
  • Exercise/Conversion

    Stock Options (right to buy)

    2025-11-26−23,621→ 0 total
    Exercise: $5.13Exp: 2027-01-03→ Common Stock (23,621 underlying)
Holdings

  • Common Stock

    (indirect: By Spouse)
    15,000
Footnotes (2)
  • [F1]This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $10.00 to $10.31 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F2]All of the options were fully vested and exercisable as of the transaction date.

Documents

1 file

Issuer

AMICUS THERAPEUTICS, INC.

CIK 0001178879

→
Entity typeother

Related Parties

1
  • filerCIK 0001666380

Filing Metadata

Form type
4
Filed
Nov 25, 7:00 PM ET
Accepted
Nov 26, 9:16 PM ET
Size
22.3 KB
View on SEC.gov